Objective: Arterial stiffness and peripheral artery disease (PAD) are both associated with an elevated risk of major adverse cardiac events; however, the association between arterial stiffness and PAD is less well characterized. The goal of this study was to examine the association between parameters of radial artery tonometry, a noninvasive measure of arterial stiffness, and PAD.
and poor patient outcomes; these include a strong association with cardiovascular disease risk, 3 disability, 4 and low quality of life. 5 Furthermore, PAD is associated with a significantly increased risk of death, particularly from coronary heart disease (CHD). 6, 7 Therefore, the early identification and risk stratification of PAD patients are extremely important for risk factor modification and targeted therapeutic interventions. Arterial stiffness develops in association with the pathophysiologic processes of arteriosclerosis and atherosclerosis. 8 Evidence demonstrates the relationship between arterial stiffness and CHD progression and mortality. 9, 10 The most common method for quantifying arterial stiffness is based on the characteristics of the pulse wave generated with each heartbeat. Measuring the pulse wave at two points of known distance, usually the common carotid and femoral arteries, yields the pulse wave velocity (PWV). Because less wall compliance translates into higher velocity, PWV is considered the "gold standard" measure of arterial stiffness. [11] [12] [13] As each pulse wave travels forward, some of it is reflected in a retrograde fashion. 14 Pulse wave analysis (PWA) examines each waveform, which is the combination of a forward and reflected pulse wave. Stiffer arteries will reflect waves Heart Association Student Scholarship (G.J.Z.). Furthermore, this work was supported by start-up funds from the University of California, San Francisco earlier in diastole, leading to a higher augmented pressure, which refers to the increase in pressure from the reflected wave. 13, 15, 16 Augmentation index (AIX) is the ratio of the augmented pressure, which is the difference between the first and second systolic peaks, and the pulse pressure, expressed as a percentage. 17 A higher AIX is an indirect measure of greater arterial stiffness. 12, 18 Although PWV and AIX are both accepted noninvasive methods, AIX measured by radial artery tonometry requires only one measurement site. 12, 19 Whereas many studies have linked arterial stiffness to CHD, the relationship between arterial stiffness and PAD is less well characterized. Furthermore, compared with PWV, even fewer studies have examined the link between AIX, as measured by radial artery tonometry, and PAD. The goals of this study were to investigate the relationship between PAD and arterial stiffness as measured by the AIX and to identify the covariates related to this association. We hypothesized that the central and peripheral AIX are independently associated with PAD. Concurrently, we hypothesized that PWV is also associated with the presence of PAD.
METHODS

Study participants.
A cross-sectional sample of 134 patients was recruited from a vascular surgery outpatient clinic between February 2012 and September 2016. Patients were considered to have PAD if they exhibited symptomatic claudication with an ankle-brachial index (ABI) that was abnormal (<0.9) or if they had a history of symptomatic PAD and had previously undergone peripheral revascularization (n ¼ 101). Controls were patients with normal ABI (>0.9) and no history of PAD, coronary artery disease, or cerebrovascular disease (n ¼ 33). To be eligible for inclusion, all participants had to be at least 35 years old to be representative of the PAD population at the San Francisco Veterans Affairs Medical Center. Individuals with significant renal (creatinine concentration $2 mg/dL), hepatic (Child-Pugh class $B), nonvascular inflammatory (eg, rheumatoid arthritis or those requiring immunosuppressive medications), or concurrent severe acute disease were excluded.
Basic demographic variables collected on all participants included age, sex, race, and comorbidities. Blood pressure was assessed at the brachial artery, and an ABI was calculated for each lower extremity using standard techniques. 20 Participants were asked to complete the Post-traumatic stress disorder ChecklistdCivilian version, with post-traumatic stress disorder defined as a score $40. 21 Depression was assessed using the nine-item PWA. PWA was performed using the SphygmoCor applanation tonometer (AtCor Medical, Sydney, Australia). Patients were positioned supine on an examination table and allowed to rest for a minimum of 5 minutes. The brachial artery blood pressure was measured, and the right arm was abducted 15 degrees with the hand supinated for access to the radial artery. The tonometer was applied to the radial artery, and SphygmoCor's proprietary software calculated the AIX as well as a quality index. AIX is defined as [augmented pressure/(systolic blood pressure À diastolic blood pressure)]; whereas peripheral AIX is calculated directly, this software uses established transfer equations to approximate the central artery waveforms using recordings from the radial artery in a process that has been previously validated by invasive methods. 23 Because central AIX varies as a function of heart rate, all measurements were normalized to 75 beats/min, consistent with previous studies. 11, 17 The quality index is a summary measure calculated by the proprietary SphygmoCor software and based on variability in the recorded waveforms (eg, pulse height variation). A higher quality index reflects less waveform variability and is assumed to be of higher quality. Multiple recordings (up to four) were conducted for each patient with the goal of achieving at least one measurement with a quality index >80. The measurement with the highest quality index was recorded.
PWV. Patients were positioned supine on an examination table and allowed to rest for a minimum of 5 minutes. The brachial artery blood pressure was measured, and three electrocardiography leads were applied. The distances from the sternal notch to the right common carotid and right common femoral arteries were measured and recorded. Using the SyphmoCor applanation tonometer, waveforms were captured at both the common carotid and common femoral artery sites to calculate a carotid-femoral PWV. The examination with the lowest pulse-transit standard deviation was recorded.
Quality control. To ensure that only the highest quality tonometry data were used, all PWA and PWV data were reviewed and rated following a strict protocol by two reviewers (G.J.Z. and K.A.S.). Quality criteria were established in accordance with the manufacturer's guidelines. These reviewers had 100% inter-rater agreement. For PWA, data that had a quality index <80 were discarded.
Minor quality criteria included a pulse height $80, height variation #5%, and diastolic variation #5%. To be considered for inclusion, at least two of the minor criteria also had to be met. For PWV, a carotid-femoral pulsetransit standard deviation #10% was required for inclusion.
Eight participants had tonometry data of insufficient quality and were dropped from further analysis. Therefore, high-quality PWA data for central AIX were obtained on 126 participants (PAD, 93; control, 33). Peripheral AIX data were missing for two participants and were dropped for two others because their values were more than three standard deviations above the mean. This resulted in peripheral AIX data on 122 patients (PAD, 89; control, 33). In addition, quality PWV data were obtained on 33 patients (PAD, 16; control, 17).
Statistical analysis. Data analysis was performed using Stata version 14 (StataCorp, College Station, Tex). Twotailed unpaired t-tests and Fisher exact test were used to test for differences between PAD and control groups on variables of interest. Log values of CRP were used because of its right-skewed distribution. Multivariable logistic regression models were used to test whether central AIX and peripheral AIX were independently associated with PAD after adjustment for potential confounders. To determine which variables to include in the multivariable model, a univariate screening analysis was performed with PAD as the outcome while adjusting for either central AIX at 75 beats/min or peripheral AIX as each covariate was added. Covariates with a P < .10 were included in the final model. All variables in Table I were screened for inclusion in the multivariable model except for coronary artery disease and prior peripheral revascularization because these variables were used to separate participants into controls and PAD patients and thus were completely collinear with PAD. ABI was also excluded for similar reasons. In instances in which related variables met criteria for inclusion (eg, systolic blood pressure and hypertension), the underlying disorder (eg, hypertension) was preferentially selected to avoid overfitting the model.
RESULTS
Compared with controls (n ¼ 33), subjects with PAD (n ¼ 93) were significantly older; they were more likely to have hypertension, hyperlipidemia, and diabetes and had smoked a greater number of pack-years. Those with PAD also had significantly higher systolic blood pressure, lower LDL levels, and lower eGFR. The paradoxically lower LDL levels in the PAD group likely corresponded to their higher rate of statin use. In addition, subjects with PAD were more likely to take aspirin and beta blockers. Of note, the controls, who were recruited from an outpatient vascular surgery clinic, had a relatively high prevalence of various atherosclerotic risk factors. For example, 61% of controls had hypertension and 64% had hyperlipidemia, whereas there was no between-group difference for CRP (Table I) .
Analysis of the PWA data demonstrates that subjects with PAD had significantly higher central AIX at 75 beats/min (25.5 6 8.9 vs 19.6 6 8.7; P ¼ .002) and peripheral AIX (91.3 6 14.3 vs 81.8 6 11.5; P < .001; Table II) . A subgroup analysis of nondiabetic participants (PAD, 59; control, 28) found a similarly elevated AIX in PAD vs controls (central AIX, 26.3 6 8.5 vs 18.8 6 9.0 [P < .001]; and peripheral AIX, 93.5 6 13.8 vs 81.6 6 11.5 [P < .001]). A Pearson correlation between central and peripheral AIX revealed a high degree of inter-relatedness between the two measures (r 120 ¼ 0.762; P < .001), with variation in one explaining 58% of the variability in the other (Fig) . For the 33 subjects with high-quality PWV data (PAD, 16; controls, 17), subjects with PAD had a higher velocity (9.8 6 2.7 vs 7.6 6 3.0 m/s; P ¼ .034), consistent with stiffer central arteries.
To determine whether central AIX and peripheral AIX were associated with PAD independent of potential confounders, a series of univariate logistic regression analyses were performed between PAD and each potential confounder while adjusting for either central AIX or peripheral AIX. All covariates with a resulting P value < .10 were added to the final model, and adjustment for age and race was also made because they are frequent confounders. The resulting multivariable model adjusted for several known risk factors for PAD and included the following: age, race, hypertension, diabetes, hyperlipidemia, pack-years, and eGFR (Tables III and IV) . The multivariable models revealed that central AIX normalized to 75 beats/min (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.01-1.15; P ¼ .026) and peripheral AIX (OR, 1.07; 95% CI, 1.02-1.12; P ¼ .009) were independently associated with higher odds of PAD. This corresponds to a 2.1-fold increased odds of PAD for each 10-unit increase in central AIX normalized to 75 beats/ min (OR, 2.07; 95% CI, 1.09-3.93; P ¼ .026) and a 1.9-fold increased odds of PAD for each 10-unit increase in peripheral AIX (OR, 1.94; 95% CI, 1.18-3.20; P ¼ .009). Central AIX (OR, 1.09; 95% CI, 1.01-1.18; P ¼ .021) and peripheral AIX (OR, 1.08; 95% CI, 1.02-1.14; P ¼ .010) remained significantly associated with PAD when medication use was added to the multivariable models. The only other variables that remained significantly associated with PAD in the multivariable models were number of pack-years smoked (both models) and hypertension (central AIX model only; Tables III and IV) .
Finally, an analysis was performed to determine the extent to which the presence of hypertension influences the relationship between AIX and PAD. Participants with hypertension had higher central AIX (24.5 6 9.1 vs 21.2 6 9.5; P ¼ .14) and peripheral AIX (90.0 6 14.3 vs 82.4 6 12.2; P ¼ .02), but only the difference in peripheral AIX reached statistical significance. A univariate analysis of PAD and hypertension, adjusting for either central AIX (OR, 6.43; 95% CI, 2.25-18.4; P < .01) or peripheral AIX (OR, 5.39; 95% CI, 1.89-15.3; P < .01), found that hypertension was significantly associated with PAD. However, the results of the multivariable model demonstrate that central and peripheral AIX remain significantly associated with PAD, whereas hypertension remains significantly associated with PAD only in the model for central AIX (Tables III and IV) . Therefore, despite the influence of hypertension and several between-group differences in atherosclerotic risk factors that reached statistical significance (Table I) , adjusting for these factors demonstrated that AIX remained significantly and independently associated with PAD.
DISCUSSION
In one of the largest studies in a PAD population, this study found that central AIX normalized to 75 beats/ min and peripheral AIX are associated with PAD, independent of other atherosclerotic risk factors, in a cohort of vascular surgery clinic patients. These results on arterial stiffness and AIX in PAD supports findings of prior research. Khaleghi and Kullo demonstrated in 475 participants, including 20 with PAD, that AIX was inversely correlated with ABI. 24 A supporting study in 65 PAD patients by Mosimann et al also found a negative correlation between AIX and ABI. 25 The present study did not examine the relationship between ABI and AIX because several PAD patients who had undergone 26 Zagura et al also saw a difference in PWV and AIX for PAD vs controls in an unadjusted analysis. 27 Tsuchikura et al found that 83 PAD patients had higher PWV than controls with no atherosclerotic disease, even when controlling for potential confounders, but they did not assess the AIX. 28 In a prospective cohort of 145 PAD patients, Pradeepa et al found an association between AIX and PAD, but this association was lost when adjusting for age. 29 Finally,
Beckmann et al demonstrated a higher central AIX in abdominal aortic aneurysm and PAD patients compared with healthy controls, but their control group was significantly younger and healthier than controls in this study, which also included patients with aneurysmal disease. 17 Overall, this study adds to the literature by demonstrating in one of the largest samples an independent association between AIX and PAD. This was Peripheral tonometry data summarize all values after two outliers >3 SD from the mean were dropped.
robust enough to maintain significance despite comparison to controls with high prevalence of atherosclerotic risk factors.
With new research emphasizing the importance of studying arterial stiffness in vascular disease, the pathophysiologic mechanisms underlying the development of arterial stiffness are becoming clearer. Stiffness is related to many CHD risk factors, including age, diabetes, smoking, renal function, and lack of exercise. 15, 30, 31 The arterial stiffness observed in PAD appears to be the result of both intrinsic changes in the quality of the arterial wall and its thickness, although the intrinsic properties have a proportionally larger effect. 32 Therefore, arterial stiffness is the result of more than hypertension and arterial thickness. Collagen and elastin contribute to the elastic properties of the arterial wall. Abnormalities in the matrix metallopeptidase 9 and transforming growth factor ß1 pathway, which controls collagen turnover, contribute to arterial stiffness. 19 Stiffness has also been associated with inflammatory conditions and markers of such conditions, such as CRP. 16 Inflammatory pathways are proposed to increase stiffness through several mechanisms, including decreased nitric oxide production, elastin and collagen degradation, increased smooth muscle cell migration to the intima, and swelling of the extracellular matrix. 33 In addition, activation of the renin-angiotensin-aldosterone system along with physical forces mediates the association between hypertension and the development of arterial stiffness. 15 However, the results of this study demonstrate that hypertension cannot explain the entire association between arterial stiffness, as measured by AIX, and PAD. Table I were run through a bivariate analysis to screen for potential confounders. All variables with a P value < .10 in the bivariate analysis were included in the multivariable model. Age and white race were also included, despite not achieving a P value < .10 in the bivariate analysis, because they are common confounders. Sex was omitted because of the small number of female subjects. b Peripheral AIX was run as a univariate logistic regression because it was the predictor in the bivariate analysis. Table I were run through a bivariate analysis to screen for potential confounders. All variables with a P value < .10 in the bivariate analysis were included in the multivariable model. Age and white race were also included, despite not achieving a P value < .10 in the bivariate analysis, because they are common confounders. Sex was omitted because of the small number of female subjects. b Central AIX was run as a univariate logistic regression because it was the predictor in the bivariate analysis.
Finally, many of the biomarkers associated with stiffness are also associated with PAD, such as CRP, osteoprotegerin, and matrix metallopeptidase 9. 27, 34, 35 Noninvasive measures of arterial stiffness continue to show promise as clinical tools for risk stratification, but although these measures have shown usefulness in predicting CHD and CHD events, 36 there is less evidence in the PAD population. 11 Carotid-femoral PWV increases with higher Framingham cardiac risk scores, 37 and AIX is correlated with lower walking distance, 38 which might make AIX a more accurate predictor of functional performance than ABI. 14 Brand et al found that arterial tonometry measures were associated with critical limb ischemia, 39 the most advanced manifestation of PAD.
In addition, because arterial stiffness is strongly linked with the pathophysiologic development of PAD, targeting stiffness for treatment and using tonometry to measure the treatment response could be of value. Measures of arterial stiffness have been shown to improve with reduction of traditional risk factors, increased physical activity, smoking cessation, and weight loss. 9,40 Antihypertensives have been shown to reduce PWV, 41 anti-inflammatory agents reduce PWV and AIX, 33 and revascularization leads to a modest reduction in AIX. 42 Future research should examine the relationship between arterial stiffness and several inflammatory mediators as well as markers of resolution of inflammation to determine the potential pathophysiologic role of these pathways in the development of arterial stiffness and PAD. In addition, prospective observational studies should be conducted in the PAD population to establish whether arterial tonometry can be used clinically for risk stratification as well as to measure the response of arterial stiffness to treatment. An examination of the association between AIX and ABI, comorbid disease burden, and functional performance would help to determine whether AIX adds to currently used methods for risk prediction and assessment of treatment response. Last, whereas AIX is generally accepted as an indirect measure of arterial stiffness, 43 some studies have found it correlates imperfectly with PWV, 44 the gold standard measure. Future studies should more carefully examine AIX as a marker of stiffness in PAD because of its relative ease of use compared with PWV, which may make it a better candidate for widespread clinical implementation.
Limitations. A major limitation of this study is the use of a cross-sectional sample, which can only establish an association between arterial stiffness and PAD. Male subjects also made up an overwhelming majority of the sample, so assessment of sex differences in arterial stiffness, which have been previously documented, 15 could not be performed. Analysis of measures of exercise or walking distance was also not included, causing another possible limitation because exercise may confound or mediate the relationship between arterial stiffness and PAD. In addition, the inclusion of PAD patients with prior revascularization excluded examination of the relationship between AIX and ABI. Furthermore, although this study went beyond much of the previous literature in screening the tonometry data for only the highest quality data, 68% of PWV data was dropped because of insufficient quality. However, this may be a limitation of the technique itself. Compared with PWA, PWV may require a greater learning curve. In a PAD population with aortoiliac disease, carotid-femoral PWV could be subject to systematic error, whereas radial artery tonometry would be unaffected, assuming there is no subclavian disease. In fact, PWV has been shown to be paradoxically decreased in advanced critical limb ischemia due to severe aortoiliac disease, whereas the central AIX remains elevated. 39 
CONCLUSIONS
This study provides further evidence in support of studies that have demonstrated an independent association between AIX, as measured by radial artery tonometry, and PAD, expanding understanding of the physiologic properties of vessels in a disease state. In addition, the association was robust enough to maintain significance despite comparison to a control group with significant atherosclerotic risk factors as well as in multivariable models that controlled for these risk factors. Future studies are needed to examine the potential role of radial artery tonometry in the early identification of PAD and to stratify the risk of patients with known disease. One potential method for further characterizing the importance of AIX as a noninvasive measure for people with PAD is through comparison with other established measures, such as flow-mediated dilation. 
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